ADA: New Research Delves Into Genetic Risk for Obesity

Share this content:
ADA: New Research Delves Into Genetic Risk for Obesity
ADA: New Research Delves Into Genetic Risk for Obesity

(HealthDay News) -- New research offers potential clues as to why children of obese mothers are at increased risk for obesity. The study was scheduled to be presented Tuesday at the annual meeting of the American Diabetes Association, held from June 5 to 9 in Boston.

Previous studies have provided clear evidence that children of obese parents are more likely to be obese. The new research indicates that while in the womb, the cells of children of obese mothers may be programmed to accumulate extra fat, or develop differences in metabolism that could lead to insulin resistance.

The researchers extracted stem cells from donated umbilical cords of infants of obese and normal-weight mothers and grew the cells into fat and muscle cells in the lab. Compared to those from normal-weight mothers, the lab-grown cells from obese mothers had 30 percent more fat. Further analysis is needed to determine if the cells from obese mothers also have altered metabolism.

"At this point, because this is fairly preliminary, we don't know how these differences in cells grown in the lab correspond to the physiology of these children after birth," Kristen Boyle, Ph.D., assistant professor at the University of Colorado School of Medicine in Denver, said in an American Diabetes Association news release. "But it's clear that there is an inherent propensity toward more fat content in the cells from offspring of obese moms, in culture. We also know that the fat accumulation in these cells corresponded to the baby's fat mass at birth. The next step is to follow these offspring to see if there is a lasting change into adulthood."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »